Back to calendar
BridgeBio Pharma, Inc. (BBIO) Earnings
BBIO reports earnings on Thursday, October 29, 2026
earnings report
October 29, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.61
Actual EPS: $-0.78
EPS surprise: -35.51%
Company overview
Market Cap$15.0B
PriceUSD 76.59
EPS (TTM)-3.57
52-week high93.42
52-week low48.78
SectorHealth Technology
IndustryBiotechnology
Employees839